Occlutech AG Company Profile

15:41 EDT 21st September 2017 | BioPortfolio

News Articles [0 Results]


Drugs and Medications [0 Results]


Clinical Trials [4 Associated Clinical Trials listed on BioPortfolio]

Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Heart Failure Patients

This study aims to investigate safety and efficacy of Occlutech® AFR device in patients with HFrEF (Heart failure with reduced ejection fraction) and HFpEF (Heart failure with preserved e...

Prospective, Non-randomized, Safety and Efficacy Study of a New Occluder Design for Minimally Invasive Closure of the Left Atrial Appendage (LAA) in Patients With Atrial Fibrillation

This is a prospective, non-randomized, study of the safety and efficacy of the Occlutech® LAA occluder indicated for percutaneous LAA closure in adult male or female patients with atrial...

Follow-up Registry to Monitor the Efficacy and Safety of the Occlutech PLD Device

Collect patient data and to monitor the clinical use (safety and efficacy) of the device

MitraClip® and Hemodynamic Effects of Iatrogenic Atrial Septum Defect Closure

Aim of this prospective trial is to assess the hemodynamic effects of a MitraClip procedure caused iatrogenic arterial septal defect (iASD) and the functional changes after interventional ...

More Information about "Occlutech AG" on BioPortfolio

We have published hundreds of Occlutech AG news stories on BioPortfolio along with dozens of Occlutech AG Clinical Trials and PubMed Articles about Occlutech AG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Occlutech AG Companies in our database. You can also find out about relevant Occlutech AG Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record